151 related articles for article (PubMed ID: 19442229)
1. Implication of aberrant glycosylation in cancer and use of lectin for cancer biomarker discovery.
Kim YS; Yoo HS; Ko JH
Protein Pept Lett; 2009; 16(5):499-507. PubMed ID: 19442229
[TBL] [Abstract][Full Text] [Related]
2. Lectin biosensors in cancer glycan biomarker detection.
Silva MLS
Adv Clin Chem; 2019; 93():1-61. PubMed ID: 31655728
[TBL] [Abstract][Full Text] [Related]
3. Enrichment and identification of glycoproteins in human saliva using lectin magnetic bead arrays.
Caragata M; Shah AK; Schulz BL; Hill MM; Punyadeera C
Anal Biochem; 2016 Mar; 497():76-82. PubMed ID: 26743719
[TBL] [Abstract][Full Text] [Related]
4. Overview of Characterizing Cancer Glycans with Lectin-Based Analytical Methods.
Pearson AJ; Gallagher ES
Methods Mol Biol; 2019; 1928():389-408. PubMed ID: 30725466
[TBL] [Abstract][Full Text] [Related]
5. Glycosylation markers in cancer.
Silsirivanit A
Adv Clin Chem; 2019; 89():189-213. PubMed ID: 30797469
[TBL] [Abstract][Full Text] [Related]
6. Cancer biomarker discovery: lectin-based strategies targeting glycoproteins.
Clark D; Mao L
Dis Markers; 2012; 33(1):1-10. PubMed ID: 22710864
[TBL] [Abstract][Full Text] [Related]
7. Role of lectin microarrays in cancer diagnosis.
Syed P; Gidwani K; Kekki H; Leivo J; Pettersson K; Lamminmäki U
Proteomics; 2016 Apr; 16(8):1257-65. PubMed ID: 26841254
[TBL] [Abstract][Full Text] [Related]
8. Lectin-based biosensors as analytical tools for clinical oncology.
Silva MLS
Cancer Lett; 2018 Nov; 436():63-74. PubMed ID: 30125611
[TBL] [Abstract][Full Text] [Related]
9. Glycosylation in cancer: its application as a biomarker and recent advances of analytical techniques.
Haga Y; Ueda K
Glycoconj J; 2022 Apr; 39(2):303-313. PubMed ID: 35156159
[TBL] [Abstract][Full Text] [Related]
10. Aberrant glycosylation and cancer biomarker discovery: a promising and thorny journey.
Wang M; Zhu J; Lubman DM; Gao C
Clin Chem Lab Med; 2019 Mar; 57(4):407-416. PubMed ID: 30138110
[TBL] [Abstract][Full Text] [Related]
11. Use of Lectin-based Affinity Techniques in Breast Cancer Glycoproteomics: A Review.
Lastovickova M; Strouhalova D; Bobalova J
J Proteome Res; 2020 May; 19(5):1885-1899. PubMed ID: 32181666
[TBL] [Abstract][Full Text] [Related]
12. Post-translational modifications in tumor biomarkers: the next challenge for aptamers?
Díaz-Fernández A; Miranda-Castro R; de-Los-Santos-Álvarez N; Lobo-Castañón MJ
Anal Bioanal Chem; 2018 Mar; 410(8):2059-2065. PubMed ID: 29353432
[TBL] [Abstract][Full Text] [Related]
13. Protein biomarkers in cancer: natural glycoprotein microarray approaches.
Zhao J; Patwa TH; Lubman DM; Simeone DM
Curr Opin Mol Ther; 2008 Dec; 10(6):602-10. PubMed ID: 19051138
[TBL] [Abstract][Full Text] [Related]
14. Aberrant glycosylation as biomarker for cancer: focus on CD43.
Tuccillo FM; de Laurentiis A; Palmieri C; Fiume G; Bonelli P; Borrelli A; Tassone P; Scala I; Buonaguro FM; Quinto I; Scala G
Biomed Res Int; 2014; 2014():742831. PubMed ID: 24689054
[TBL] [Abstract][Full Text] [Related]
15. Sweetening the pot: adding glycosylation to the biomarker discovery equation.
Drake PM; Cho W; Li B; Prakobphol A; Johansen E; Anderson NL; Regnier FE; Gibson BW; Fisher SJ
Clin Chem; 2010 Feb; 56(2):223-36. PubMed ID: 19959616
[TBL] [Abstract][Full Text] [Related]
16. Detection of N-glycolylneuraminic acid biomarkers in sera from patients with ovarian cancer using an engineered N-glycolylneuraminic acid-specific lectin SubB2M.
Shewell LK; Wang JJ; Paton JC; Paton AW; Day CJ; Jennings MP
Biochem Biophys Res Commun; 2018 Dec; 507(1-4):173-177. PubMed ID: 30415777
[TBL] [Abstract][Full Text] [Related]
17. Semi-Automated Lectin Magnetic Bead Array (LeMBA) for Translational Serum Glycoprotein Biomarker Discovery and Validation.
Dutt M; Duong MN; Bringans S; Richards RS; Lipscombe R; Hill MM
Methods Mol Biol; 2023; 2628():395-411. PubMed ID: 36781799
[TBL] [Abstract][Full Text] [Related]
18. Identification of GlcNAcylated alpha-1-antichymotrypsin as an early biomarker in human non-small-cell lung cancer by quantitative proteomic analysis with two lectins.
Jin Y; Wang J; Ye X; Su Y; Yu G; Yang Q; Liu W; Yu W; Cai J; Chen X; Liang Y; Chen Y; Wong BH; Fu X; Sun H
Br J Cancer; 2016 Mar; 114(5):532-44. PubMed ID: 26908325
[TBL] [Abstract][Full Text] [Related]
19. Pros and cons of using aberrant glycosylation as companion biomarkers for therapeutics in cancer.
Kang JG; Ko JH; Kim YS
BMB Rep; 2011 Dec; 44(12):765-71. PubMed ID: 22189678
[TBL] [Abstract][Full Text] [Related]
20. Development and application of a novel recombinant Aleuria aurantia lectin with enhanced core fucose binding for identification of glycoprotein biomarkers of hepatocellular carcinoma.
Norton P; Comunale MA; Herrera H; Wang M; Houser J; Wimmerova M; Romano PR; Mehta A
Proteomics; 2016 Dec; 16(24):3126-3136. PubMed ID: 27650323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
